We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Specific internalization and synergistic anticancer effect of docetaxel-encapsulated chitosan-modified polymeric nanocarriers: a novel approach in cancer chemotherapy.
- Authors
Asthana, Shalini; Gupta, Pramod; Konwar, Rituraj; Chourasia, Manish
- Abstract
Nanocarriers can be surface engineered to increase endocytosis for applications in delivery of chemotherapeutics. This study investigated the chitosan (CS)-mediated effects on the anticancer efficacy and uptake of docetaxel-loaded nanometric particles (<250 nm) by MCF-7 tumor cells. Herein, negatively charged poly lactic- co-glycolic acid (PLGA) nanoparticles (−18.4 ± 2.57 mV, 162 ± 6.34 nm), poorly endocytosed by the MCF-7 cells, were subjected to surface modification with CS. It demonstrated significant increase (>5-fold) in intracellular uptake as well as antitumor efficacy of modified nanoparticles (NPs) that explicate the possibility of saccharide marker-mediated tumor targeting along with synergism via proapoptotic effect of CS. Additionally, high positivity of optimized tailored nanocarrier (+23.3 ± 2.02 mV, 242.8 ± 9.42 nm) may have accounted for the increased adsorption-mediated endocytosis, preferably toward tumor cells with negative potential. Developed drug carrier system showed high stability in human blood which is in compliance with mucoadhesive property of CS. Transmission electron microscopy technique was applied to observe shape and morphological features of NPs. Furthermore, in vivo tissue toxicity study revealed safe use of drug at 20 mg/kg dose in nanoparticulate form. Moreover, the enhanced in vitro uptake of these NPs and their cytotoxicity against the tumor cells along with synergistic effect of CS clearly suggest that CS-modified carrier system is a promising candidate for preclinical studies to achieve wider anti-tumor therapeutic window and lower side effects.
- Subjects
DRUG synergism; ANTINEOPLASTIC agents; DOCETAXEL; DRUG carriers; CHITOSAN; CANCER chemotherapy; NANOMEDICINE
- Publication
Journal of Nanoparticle Research, 2013, Vol 15, Issue 9, p1
- ISSN
1388-0764
- Publication type
Article
- DOI
10.1007/s11051-013-1864-2